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Results: Key improvements included two of nine initial process 
steps being eliminated, decreased time between planning and 
treatment (average nine days down to six days), implementing 
visual management and accountability for wait times at each 
step/role/individual, remote plan approvals by ROs, daily and 
weekly huddles in dosimetry, and weekly posting of results. In 
the seventh month, the 90% RTT-to-RTx interval was 2.6 weeks. 
Managing change required and benefited from engagement of 
multiple stakeholders including patients, radiation therapists, 
treatment planners, booking clerks, radiation oncologists (ROs), 
medical physicists, management, and data analysts. The process 
improvement was sustained. Active reinforcement of ownership, 
measurement and continuous improvement are ongoing as are 
wait time improvement projects among the lung and GU patient 
groups. 
Conclusions: Formal process improvement using LEAN and Six 
Sigma principles resulted in a significant and sustained 
improvement in RTT-to-RTx timeliness and a cultural change in 
accountability, the use of visual monitoring, and staff 
engagement to sustain the process improvement.  
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Purpose: To determine the Planning Target Volume (PTV) margin 
for Hypofractionated Partial Breast Irradiation (HPBI), a novel 
technique intended to provide local control in breast cancer 
patients not eligible for surgical resection using 40 Gy in 5 
fractions prescribed to the gross disease. 
Methods and Materials: The van Herk formalism, a widely 
accepted PTV margin recipe, is M = 2.5∑ + 0.7σ, with ∑ and σ 
standard deviations (SDs) representing systematic and random 
uncertainties, respectively, which were quantified through 
retrospective analysis of cone-beam computed tomography 
(CBCT) data sets for ten patients. During simulation and 
treatment, patients were immobilized using a wing board and an 
evacuated bag. CBCT was acquired prior to treatment delivery 
(prefraction) for setup verification. The prefraction CBCT was 
rigidly registered to planning four-dimensional computed 
tomography (4DCT) using the chest wall and tumour and 
translational couch shifts were applied as needed. CBCT was also 
acquired following treatment delivery (post-fraction) for 
intrafractional verification. This clinical workflow was faithfully 
reproduced in Pinnacle (Philips Medical Systems) to yield residual 
setup and intrafractional error through translational shifts and 
rigid registrations (ribs and sternum) of prefraction CBCT to 4DCT 
and post-fraction CBCT to pre-fraction CBCT, respectively. All 
ten patients included in this investigation were medically 
inoperable; the median age was 84 (range, 52-100) years; one 
patient was male and nine patients were female. 
Results: The image quality of the CBCT was sufficient for 
required registrations. Systematic (and random) setup 
uncertainties detected for the left-right, craniocaudal and 
anteroposterior directions were 2.1 (2.5) mm, 1.6 (3.6) mm and 
1.7 (2.8) mm. Net systematic (and random) uncertainty was 
determined to be 2.2 (3.2) mm. Rotations > 2º in any axis 
occurred on 11/72 (15.3%) registrations. 
Conclusions: Preliminary results suggest a non-uniform setup 
margin of 7.1 mm, 6.6 mm and 6.3 mm for the left-right, 
craniocaudal and anteroposterior directions is required. This 
investigation is ongoing, though published results from similar 
studies are consistent with the above findings. Determination of 
margins in breast radiotherapy is a paradigm shift, but a 
necessary step in moving towards hypofractionated regiments, 
which may ultimately redefine the standard of care for this 
select patient population. 
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Purpose: A review of patient preparedness for prostate 
radiotherapy (RT) showed that thirteen out of 55 patients were 
prepared and 42/55 (76%) needed to be re-scanned due to 
inadequate bladder or rectum filling. To decrease additional 
scans, associated costs and patient satisfaction, a video outlining 
proper preparation for prostate RT was created. The purpose of 
this study was to determine the effectiveness of a video versus 
an educational handout to improve CT planning preparation for 
prostate RT. 
Methods and Materials:  A video outlining the importance of 
rectal and bladder preparation was created and revised based on 
clinical feedback from an interprofessional team consisting of 
patients, radiation oncologists, nurses and radiation therapists. 
Patients were accrued by the research assistant (RA) in new 
patient clinics or over the phone and were randomly assigned to 
either the control group (received handout) or the experimental 
group (watched video and received handout). At the CT planning 
appointment, planning therapists collected bladder and rectal 
volume based on departmental guidelines. The rectal volume 
was measured at the maximum point within the prostate volume. 
These measurements were used to determine if patients were 
prepared or needed to be rescanned. At the CT simulation 
appointment, the RA collected this data as well as patient 
satisfaction with the preparation materials (handout or video). A 
Likert scale was used to determine patient satisfaction 
outcomes. 
Results: Fifty-eight out of 65 patients completed the study, with 
29 patients in each arm. The mean age in the control group was 
71 and 68 in the experimental group. In the control group, 23/29 
were prepared for planning CT scan and 6/29 needed to be 
rescanned due to full rectum (5/28), empty bladder (0/28) or 
both (2/28), with one person needing to be rescanned twice. In 
the experimental group, 22/29 were prepared and 7/29 needed 
to be rescanned due to full rectum (4/28) or empty bladder 
(5/28), with two people needing to be rescanned twice. There 
was no statistical difference between groups in re-scanning rate. 
Most patients were planned within 11 days after consenting to 
the study. Patients in the experimental group watched the video 
1.4 times on average and expressed feeling more prepared for 
their appointment than the control group. Patients indicated 
that they liked the length of the video and would recommend the 
video to other patients with prostate cancer.  
Conclusions:  The CT re-simulation rate was 55% lower in the 
control group and 52% lower in the experimental group compared 
to the initial review. Despite no statistical difference in re-
simulation rates between the groups, patient satisfaction in the 
experimental group was higher. 
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Purpose: Cavity radiosurgery has largely supplanted whole-brain 
radiotherapy for patients, with solitary brain metastasis, who 
require surgical excision. However, coverage of the operative 
tract, in addition to tumour bed, may lead to large treatment 
volumes and inter-observer variability. We hypothesized that 
pre-operative radiosurgery may reduce target volume size and 
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inter-observer variability compared to post-operative 
radiosurgery. 
Methods and Materials: We identified 10 consecutive patients, 
with solitary brain metastasis, treated with post-operative cavity 
radiosurgery. Pre- and post-operative axial T1 contrast MRI were 
co-registered with the planning CT scans. Three radiation 
oncologists independently contoured the target volumes on the 
pre- and post-operative imaging and CyberKnife treatment plans 
were generated. The following parameters were evaluated in the 
two plans: Mean target volume (cc), 50% isodose volume(cc), 
Inter-observer variability (Jaccard Index JI) and Conformity Index 
(CI). Results were analyzed with STATA version 14. 
Results: Radiosurgery doses ranged from 18 Gy in 1 to 30 Gy in 5 
fractions depending on the location and volume (Median 24 Gy in 
3 fractions). There was no significant difference in the mean 
target volume, nor 50% isodose volume, between pre- and post-
operative strategies. (17.6 +- SD 12.3 versus 19.4+-15 cc, p = 
0.80; 61.7 +-37.7 versus 77.7 +- 69.0 cc, p = 0.65). There was 
significantly less inter-observer variability and improved 
conformity in the pre-operative group (Mean JI 0.84+-0.04 versus 
0.70+-0.13, p = 0.005; Mean CI 1.32 +- 0.09 versus 1.45 +-0.14, p 
= 0.01). Planned subgroup analysis did not reveal any significant 
difference (between pre- versus post-op) in the mean volume of 
cystic versus non-cystic metastasis. Deep lesions (> 2.5 cm from 
dura) had a larger post-operative target volume (25.8+-17.3 
versus 12.3+-9.3 cc, p = 0.06) compared to superficial lesions. 
Conclusions: Pre-operative radiosurgery has less inter-observer 
variability and improved plan conformity. However, there was no 
difference in mean target volume between the pre- versus post-
operative radiation. Contouring guidelines, and peer review, may 
help to reduce inter-observer variability for cavity radiosurgery.  
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Purpose: In the setting of limited metastatic burden of disease, 
stereotactic body radiotherapy (SBRT) has been shown to achieve 
high local control rates. It has been hypothesized that SBRT may 
translate to better quality of life by delaying the need for 
systemic chemotherapy and possibly increased survival. There is 
limited published literature on the efficacy of SBRT in limited 
nodal metastases. The primary objective is to report the clinical 
outcome of SBRT in a series of patients with either solitary or 
oligometastases from various tumours to lymph nodes. 
Methods and Materials: A retrospective study of patients treated 
on a provincial protocol with SBRT to metastatic lymph nodes 
(March 2010 and June 2015) was conducted. Primary endpoint 
was local control (LC) and chemotherapy free survival following 
SBRT. Secondary endpoints included toxicities, progression-free 
survival (PFS), and overall survival (OS). 
Results: Eighteen patients underwent SBRT to a metastatic 
lymph node with a mean age of 61.8 years (range: 20-84 years) 
and a median follow up of 22 months. There were four (22%) 
liver, seven (39%) colorectal, four (22%) pancreatic, one (6%) 
esophageal, one (6%) gallbladder and one (6%) lung primary. 
Eleven (61%) patients had lymph node metastases as part of their 
initial presentation of metastatic disease. Seven patients (39%) 
had systemic therapy prior to SBRT, with the majority of patients 
(71%) receiving two lines of chemotherapy. Eight patients had 
solitary metastatic disease at the time of SBRT, with all patients 
having four or fewer total sites of metastases. Average size of 
the lymph node metastases was 2.3 cm (range: 0.8-6.2 cm). RT 
doses were 31 to 60 Gy in four to ten fractions, with 44% of 
patients receiving 35 Gy in 5 fractions. At one year, LC was 93% 
and chemotherapy-free survival from the time of SBRT was 58%. 
PFS at one and two years were 42% and 18% respectively. One 
and two year OS were 92% and 84%. There were no Grade 3 or 
higher toxicities reported. On univariate analysis, absence of 
prior chemotherapy and non-colorectal primary approached 
significance for improved local control (both p = 0.052) while 
solitary metastases was associated with improved PFS (p = 0.029) 
and trended to improved chemotherapy-free survival (p = 0.066). 
Conclusions: In this single institution study, SBRT to 
oligometastatic lymph nodes provides high local control and a 
moderate chemotherapy-free interval with acceptable 
toxicities. Progression of disease remains prominent in these 
patients. Larger cohort studies are required to better identify a 
subset of patients with oligometastatic nodal disease who 
benefit the most from SBRT. 
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Purpose: The management of retroperitoneal sarcomas (RPS) 
may include pre-operative radiotherapy (RT) and surgery. As RPS 
often require multi-visceral resection, combined treatment of 
RPS can be associated with substantial toxicity as radiation 
sensitive organs may be affected by pre-op RT. We aimed to 
examine how these treatments related toxicities affect patient 
quality of life (QOL).  
Methods and Materials: In a cross-sectional study, 25 primary 
RPS patients treated with pre-operative IMRT from 2004-2012 
were recruited and assessed for QOL (EORTC QLQ-C30) and to 
determine RT and surgery related toxicities (CTCAE V.4). 
Baseline and prospective QOL was available for 11 patients. In 
the other 14 patients cross-sectional data alone were obtained 
at different time points during their follow up (four weeks, six 
months, one year, three years, five years and 10 years post-
IMRT). Unless stated otherwise, all scores refer to the global 
domain. 
Results: Ten female and 15 male patients with a median age of 
56 (38-80) were treated with IMRT to a median dose of 50.4 Gy 
(41.4-50.4). The median maximum dimension was 13.4 cm (5.7-
28) and the majority (17/25) were liposarcomas. The median 
time from completion of RT to RPS surgery was 9.4 weeks (5-
17.4). Of the 11 patients who completed baseline QOL 
assessments, their compliance at four weeks, six months, one 
year and three years post-RT were 80%, 100%, 90%, and 100%. 
Mean pre-RT QOL was 48.5 (standard deviation (SD) 19.3). At four 
weeks post-RT, mean QOL was 57.5 (SD: 23.7) however, the 
mean diarrhea symptom scale increased from baseline (85 versus 
18.1, p < 0.001). Correspondingly, 54% of patients had 
gastrointestinal toxicities (32% G1, 56% G2 and 8% G3) by the end 
of RT. Regression slope analysis suggested that QOL significantly 
(p = 0.002) improved over the first three years. The number of 
toxicities was significantly (p = 0.002) associated with QOL over 
time. Clinically important improvement (> 10 points) from 
baseline was observed at one year (68.6, SD: 18.4). At three 
years post-RT, 88% of patients had chronic RT and/or surgery 
related toxicities of which 30% were Grade 3 toxicities. RPS 
patients who survived at least three years had significantly 
better QOL (mean: 67.2, p = 0.007 Mann-Whitney Test) relative 
to the full group at diagnosis. QOL changed little (mean: 0.31 
point/month; SD: 0.36) after three years (n = 10). RT dose, 
tumour size, patient age and gender were not associated with 
three year QOL scores.  
Conclusions: Treatment toxicities seem to contribute to QOL 
recovery during the first three years. The number of toxicities a 
patient had was significantly associated with QOL. Despite 
patients having on average 2.5 treatment-related chronic 
toxicities, QOL at three years was better than at diagnosis. 
 
 
 
 
 
